

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.15605553 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 6.02038976 |
| 3 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.85141033 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.81621817 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 5.81621817 |
| 6 | respiratory electron transport chain (GO:0022904) | 5.36333439 |
| 7 | electron transport chain (GO:0022900) | 5.22788994 |
| 8 | oxidative phosphorylation (GO:0006119) | 4.94485881 |
| 9 | viral transcription (GO:0019083) | 4.85211701 |
| 10 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.84655481 |
| 11 | translational termination (GO:0006415) | 4.71628996 |
| 12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.54443610 |
| 13 | muscle filament sliding (GO:0030049) | 4.52643064 |
| 14 | actin-myosin filament sliding (GO:0033275) | 4.52643064 |
| 15 | cotranslational protein targeting to membrane (GO:0006613) | 4.51508656 |
| 16 | protein targeting to ER (GO:0045047) | 4.47323230 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 4.43818002 |
| 18 | ribosomal small subunit biogenesis (GO:0042274) | 4.32689344 |
| 19 | regulation of cell communication by electrical coupling (GO:0010649) | 4.30475136 |
| 20 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.27745627 |
| 21 | protein localization to endoplasmic reticulum (GO:0070972) | 4.20967855 |
| 22 | tricarboxylic acid cycle (GO:0006099) | 4.15760758 |
| 23 | translational elongation (GO:0006414) | 4.14930887 |
| 24 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.07359462 |
| 25 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.07359462 |
| 26 | NADH dehydrogenase complex assembly (GO:0010257) | 4.07359462 |
| 27 | heart process (GO:0003015) | 4.02749661 |
| 28 | heart contraction (GO:0060047) | 4.02749661 |
| 29 | chaperone-mediated protein transport (GO:0072321) | 4.02211641 |
| 30 | protein complex biogenesis (GO:0070271) | 3.99531644 |
| 31 | aerobic respiration (GO:0009060) | 3.82498376 |
| 32 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.70186702 |
| 33 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.70186702 |
| 34 | regulation of skeletal muscle contraction (GO:0014819) | 3.69537805 |
| 35 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.68951825 |
| 36 | viral life cycle (GO:0019058) | 3.68536401 |
| 37 | polyketide metabolic process (GO:0030638) | 3.68353273 |
| 38 | doxorubicin metabolic process (GO:0044598) | 3.68353273 |
| 39 | daunorubicin metabolic process (GO:0044597) | 3.68353273 |
| 40 | cellular protein complex disassembly (GO:0043624) | 3.67687518 |
| 41 | actin-mediated cell contraction (GO:0070252) | 3.58530770 |
| 42 | cullin deneddylation (GO:0010388) | 3.57284933 |
| 43 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.57044588 |
| 44 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.55177593 |
| 45 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.55139189 |
| 46 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.54772192 |
| 47 | ribosomal large subunit biogenesis (GO:0042273) | 3.46156144 |
| 48 | maturation of SSU-rRNA (GO:0030490) | 3.43911220 |
| 49 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.41412316 |
| 50 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.41051527 |
| 51 | respiratory chain complex IV assembly (GO:0008535) | 3.38383104 |
| 52 | sarcomere organization (GO:0045214) | 3.35051995 |
| 53 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.33204911 |
| 54 | cytochrome complex assembly (GO:0017004) | 3.31896917 |
| 55 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.31802222 |
| 56 | translational initiation (GO:0006413) | 3.29764973 |
| 57 | ubiquinone metabolic process (GO:0006743) | 3.29306922 |
| 58 | proton transport (GO:0015992) | 3.23064405 |
| 59 | translation (GO:0006412) | 3.22306569 |
| 60 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.22184419 |
| 61 | termination of RNA polymerase III transcription (GO:0006386) | 3.22184419 |
| 62 | protein localization to mitochondrion (GO:0070585) | 3.21733894 |
| 63 | positive regulation of mitochondrial fission (GO:0090141) | 3.20897310 |
| 64 | establishment of protein localization to mitochondrion (GO:0072655) | 3.17080105 |
| 65 | hydrogen transport (GO:0006818) | 3.16877670 |
| 66 | regulation of coenzyme metabolic process (GO:0051196) | 3.15161987 |
| 67 | regulation of cofactor metabolic process (GO:0051193) | 3.15161987 |
| 68 | protein deneddylation (GO:0000338) | 3.11928637 |
| 69 | regulation of mitochondrial translation (GO:0070129) | 3.10936370 |
| 70 | cytidine metabolic process (GO:0046087) | 3.09769455 |
| 71 | cytidine catabolic process (GO:0006216) | 3.09769455 |
| 72 | cytidine deamination (GO:0009972) | 3.09769455 |
| 73 | protein targeting to membrane (GO:0006612) | 3.04140154 |
| 74 | protein complex disassembly (GO:0043241) | 3.03624890 |
| 75 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.03409067 |
| 76 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.02867390 |
| 77 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.96625556 |
| 78 | ATP biosynthetic process (GO:0006754) | 2.95938576 |
| 79 | macromolecular complex disassembly (GO:0032984) | 2.95700669 |
| 80 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.95501025 |
| 81 | branched-chain amino acid catabolic process (GO:0009083) | 2.95463879 |
| 82 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.94348823 |
| 83 | GTP biosynthetic process (GO:0006183) | 2.93969599 |
| 84 | negative regulation of heart rate (GO:0010459) | 2.93849635 |
| 85 | signal peptide processing (GO:0006465) | 2.91800903 |
| 86 | mitochondrial transport (GO:0006839) | 2.91006188 |
| 87 | regulation of cilium movement (GO:0003352) | 2.90006711 |
| 88 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.87054519 |
| 89 | intracellular protein transmembrane import (GO:0044743) | 2.86966178 |
| 90 | inner mitochondrial membrane organization (GO:0007007) | 2.86641509 |
| 91 | regulation of sarcomere organization (GO:0060297) | 2.86080123 |
| 92 | IMP metabolic process (GO:0046040) | 2.85932798 |
| 93 | skeletal muscle contraction (GO:0003009) | 2.85773529 |
| 94 | organelle disassembly (GO:1903008) | 2.85127403 |
| 95 | NADH metabolic process (GO:0006734) | 2.84798307 |
| 96 | protein-cofactor linkage (GO:0018065) | 2.84058517 |
| 97 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.82738778 |
| 98 | piRNA metabolic process (GO:0034587) | 2.81804184 |
| 99 | myofibril assembly (GO:0030239) | 2.81273942 |
| 100 | skeletal muscle tissue regeneration (GO:0043403) | 2.80179516 |
| 101 | regulation of actin filament-based movement (GO:1903115) | 2.76443648 |
| 102 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.76382144 |
| 103 | amino acid salvage (GO:0043102) | 2.75415519 |
| 104 | L-methionine salvage (GO:0071267) | 2.75415519 |
| 105 | L-methionine biosynthetic process (GO:0071265) | 2.75415519 |
| 106 | hydrogen ion transmembrane transport (GO:1902600) | 2.75321376 |
| 107 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.75247674 |
| 108 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.74725661 |
| 109 | aldehyde catabolic process (GO:0046185) | 2.73406325 |
| 110 | proteasome assembly (GO:0043248) | 2.72730770 |
| 111 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.70763320 |
| 112 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.70599465 |
| 113 | negative regulation of ligase activity (GO:0051352) | 2.70599465 |
| 114 | cellular respiration (GO:0045333) | 2.69646853 |
| 115 | sequestering of actin monomers (GO:0042989) | 2.69595686 |
| 116 | response to muscle activity (GO:0014850) | 2.69296128 |
| 117 | protein neddylation (GO:0045116) | 2.68182284 |
| 118 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.67955473 |
| 119 | platelet dense granule organization (GO:0060155) | 2.67769191 |
| 120 | iron-sulfur cluster assembly (GO:0016226) | 2.67659580 |
| 121 | metallo-sulfur cluster assembly (GO:0031163) | 2.67659580 |
| 122 | striated muscle contraction (GO:0006941) | 2.67529226 |
| 123 | succinate metabolic process (GO:0006105) | 2.65490686 |
| 124 | dopamine transport (GO:0015872) | 2.65085443 |
| 125 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.64165013 |
| 126 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.63305108 |
| 127 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.62140955 |
| 128 | cardiac myofibril assembly (GO:0055003) | 2.61763037 |
| 129 | cellular response to zinc ion (GO:0071294) | 2.59690454 |
| 130 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.56750568 |
| 131 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.56750568 |
| 132 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.55482933 |
| 133 | protein targeting to mitochondrion (GO:0006626) | 2.51277259 |
| 134 | IMP biosynthetic process (GO:0006188) | 2.50613997 |
| 135 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.47367857 |
| 136 | cellular component biogenesis (GO:0044085) | 2.47262089 |
| 137 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.47119232 |
| 138 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.46193451 |
| 139 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.46193451 |
| 140 | quinone biosynthetic process (GO:1901663) | 2.46072071 |
| 141 | ubiquinone biosynthetic process (GO:0006744) | 2.46072071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.72207368 |
| 2 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.21472776 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.07846500 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.93107766 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.88760848 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.68808279 |
| 7 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.38320929 |
| 8 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.17590646 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.08813464 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.07108487 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.01976099 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.95787717 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.74072197 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.72326330 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.69670491 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.68920962 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.64745204 |
| 18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.62951815 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.57030281 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.54323053 |
| 21 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.52920860 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.48149942 |
| 23 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.45830932 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.45495676 |
| 25 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.33556661 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.28686005 |
| 27 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.28180119 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.19658590 |
| 29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16674212 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11946366 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10709351 |
| 32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06841086 |
| 33 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.06406686 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.05760860 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96692442 |
| 36 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.93494616 |
| 37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.90014191 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.89675931 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.89024945 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.88942620 |
| 41 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.86023277 |
| 42 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85643544 |
| 43 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.81547156 |
| 44 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.77096161 |
| 45 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.76834669 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69763877 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69017397 |
| 48 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.66086342 |
| 49 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.65955386 |
| 50 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.62840624 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.62786473 |
| 52 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.57745883 |
| 53 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.57243404 |
| 54 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.53976797 |
| 55 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.53399754 |
| 56 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52428174 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52409606 |
| 58 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.49561509 |
| 59 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.46678658 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46450093 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40430275 |
| 62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39817656 |
| 63 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.38798307 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.36050607 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31800699 |
| 66 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.30158941 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29014864 |
| 68 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.28143175 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26580802 |
| 70 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.24707295 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.23794830 |
| 72 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.22655872 |
| 73 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.21477440 |
| 74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21316136 |
| 75 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21316136 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20167211 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18300811 |
| 78 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17526604 |
| 79 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16478409 |
| 80 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.16324327 |
| 81 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13865030 |
| 82 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13578612 |
| 83 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13054382 |
| 84 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.11835461 |
| 85 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10944722 |
| 86 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10879661 |
| 87 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08819983 |
| 88 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.06969295 |
| 89 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05742055 |
| 90 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05143056 |
| 91 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04880427 |
| 92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04661415 |
| 93 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04011501 |
| 94 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03817458 |
| 95 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00502475 |
| 96 | EWS_26573619_Chip-Seq_HEK293_Human | 1.00141294 |
| 97 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00022888 |
| 98 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.99907764 |
| 99 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99470271 |
| 100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97979555 |
| 101 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97619052 |
| 102 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97357107 |
| 103 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.97062033 |
| 104 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.96997128 |
| 105 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96996710 |
| 106 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96479773 |
| 107 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96159461 |
| 108 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95712474 |
| 109 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.95507848 |
| 110 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94117846 |
| 111 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.93816839 |
| 112 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93694014 |
| 113 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93496528 |
| 114 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93496528 |
| 115 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93209187 |
| 116 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.91923160 |
| 117 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.91513353 |
| 118 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91241234 |
| 119 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.90315288 |
| 120 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.90111682 |
| 121 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88393985 |
| 122 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.88155129 |
| 123 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.87795646 |
| 124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87332241 |
| 125 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86893608 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85880959 |
| 127 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85709205 |
| 128 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85051941 |
| 129 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84398148 |
| 130 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.84222738 |
| 131 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.83712585 |
| 132 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.83712585 |
| 133 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.83526921 |
| 134 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83174468 |
| 135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82887732 |
| 136 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82155869 |
| 137 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.81843903 |
| 138 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81802365 |
| 139 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.80038186 |
| 140 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78970671 |
| 141 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.77516539 |
| 142 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.77209893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000749_muscle_degeneration | 4.05739751 |
| 2 | MP0003646_muscle_fatigue | 3.86478914 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 3.55030537 |
| 4 | MP0000751_myopathy | 3.19139282 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.04664369 |
| 6 | MP0004215_abnormal_myocardial_fiber | 2.85845465 |
| 7 | MP0004036_abnormal_muscle_relaxation | 2.85770303 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.77687407 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.69802584 |
| 10 | MP0006036_abnormal_mitochondrial_physio | 2.41552961 |
| 11 | MP0000372_irregular_coat_pigmentation | 2.37798720 |
| 12 | MP0003011_delayed_dark_adaptation | 2.31591949 |
| 13 | MP0002106_abnormal_muscle_physiology | 2.18652152 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.14709927 |
| 15 | MP0004484_altered_response_of | 2.09397402 |
| 16 | MP0005330_cardiomyopathy | 1.99932841 |
| 17 | MP0005620_abnormal_muscle_contractility | 1.98465407 |
| 18 | MP0001529_abnormal_vocalization | 1.92280104 |
| 19 | MP0004147_increased_porphyrin_level | 1.90447082 |
| 20 | MP0005369_muscle_phenotype | 1.89989900 |
| 21 | MP0000759_abnormal_skeletal_muscle | 1.87362832 |
| 22 | MP0004087_abnormal_muscle_fiber | 1.86825484 |
| 23 | MP0002972_abnormal_cardiac_muscle | 1.84718781 |
| 24 | MP0005503_abnormal_tendon_morphology | 1.79302526 |
| 25 | MP0006054_spinal_hemorrhage | 1.75422544 |
| 26 | MP0000750_abnormal_muscle_regeneration | 1.74117456 |
| 27 | MP0003136_yellow_coat_color | 1.74011064 |
| 28 | MP0000747_muscle_weakness | 1.72057564 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.65219473 |
| 30 | MP0001968_abnormal_touch/_nociception | 1.63488499 |
| 31 | MP0000343_altered_response_to | 1.56293727 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.56137901 |
| 33 | MP0010386_abnormal_urinary_bladder | 1.55954119 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.54158258 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.52222912 |
| 36 | MP0008058_abnormal_DNA_repair | 1.51383578 |
| 37 | MP0006035_abnormal_mitochondrial_morpho | 1.47543824 |
| 38 | MP0001984_abnormal_olfaction | 1.46866054 |
| 39 | MP0002332_abnormal_exercise_endurance | 1.44721571 |
| 40 | MP0004130_abnormal_muscle_cell | 1.44086141 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.43959748 |
| 42 | MP0002163_abnormal_gland_morphology | 1.41687792 |
| 43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.40115559 |
| 44 | MP0005385_cardiovascular_system_phenoty | 1.37060039 |
| 45 | MP0001544_abnormal_cardiovascular_syste | 1.37060039 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.35983924 |
| 47 | MP0002102_abnormal_ear_morphology | 1.32763716 |
| 48 | MP0005410_abnormal_fertilization | 1.32254756 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.32068244 |
| 50 | MP0003279_aneurysm | 1.30870576 |
| 51 | MP0002638_abnormal_pupillary_reflex | 1.30808814 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.27927853 |
| 53 | MP0001879_abnormal_lymphatic_vessel | 1.27777199 |
| 54 | MP0005171_absent_coat_pigmentation | 1.27737017 |
| 55 | MP0003828_pulmonary_edema | 1.26962839 |
| 56 | MP0005253_abnormal_eye_physiology | 1.26629664 |
| 57 | MP0005266_abnormal_metabolism | 1.21548954 |
| 58 | MP0001188_hyperpigmentation | 1.21294408 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.21255256 |
| 60 | MP0009697_abnormal_copulation | 1.20139481 |
| 61 | MP0002269_muscular_atrophy | 1.20127296 |
| 62 | MP0009046_muscle_twitch | 1.19800515 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.18764890 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.17744233 |
| 65 | MP0003724_increased_susceptibility_to | 1.16762663 |
| 66 | MP0003123_paternal_imprinting | 1.16223501 |
| 67 | MP0002272_abnormal_nervous_system | 1.15262262 |
| 68 | MP0008995_early_reproductive_senescence | 1.15250567 |
| 69 | MP0002653_abnormal_ependyma_morphology | 1.14863665 |
| 70 | MP0003186_abnormal_redox_activity | 1.13479637 |
| 71 | MP0008872_abnormal_physiological_respon | 1.12474727 |
| 72 | MP0003195_calcinosis | 1.12208749 |
| 73 | MP0002108_abnormal_muscle_morphology | 1.12007647 |
| 74 | MP0003137_abnormal_impulse_conducting | 1.11725885 |
| 75 | MP0009780_abnormal_chondrocyte_physiolo | 1.11368641 |
| 76 | MP0009785_altered_susceptibility_to | 1.10949054 |
| 77 | MP0010630_abnormal_cardiac_muscle | 1.10081261 |
| 78 | MP0006292_abnormal_olfactory_placode | 1.07129546 |
| 79 | MP0008789_abnormal_olfactory_epithelium | 1.06212781 |
| 80 | MP0005670_abnormal_white_adipose | 1.06133226 |
| 81 | MP0005646_abnormal_pituitary_gland | 1.05986379 |
| 82 | MP0002210_abnormal_sex_determination | 1.05855008 |
| 83 | MP0005332_abnormal_amino_acid | 1.02874520 |
| 84 | MP0001764_abnormal_homeostasis | 1.01399422 |
| 85 | MP0002876_abnormal_thyroid_physiology | 1.00160917 |
| 86 | MP0004510_myositis | 0.97956191 |
| 87 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97190862 |
| 88 | MP0009745_abnormal_behavioral_response | 0.96046982 |
| 89 | MP0005671_abnormal_response_to | 0.95648945 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.95184995 |
| 91 | MP0002160_abnormal_reproductive_system | 0.93740197 |
| 92 | MP0004957_abnormal_blastocyst_morpholog | 0.93563858 |
| 93 | MP0005423_abnormal_somatic_nervous | 0.92762029 |
| 94 | MP0002009_preneoplasia | 0.92715508 |
| 95 | MP0004808_abnormal_hematopoietic_stem | 0.92136142 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.92066855 |
| 97 | MP0001929_abnormal_gametogenesis | 0.90709780 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.89776551 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.88968497 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.88625920 |
| 101 | MP0003122_maternal_imprinting | 0.87668706 |
| 102 | MP0004142_abnormal_muscle_tone | 0.85842132 |
| 103 | MP0004270_analgesia | 0.85648996 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.85562101 |
| 105 | MP0003698_abnormal_male_reproductive | 0.83443145 |
| 106 | MP0004885_abnormal_endolymph | 0.82848993 |
| 107 | MP0004233_abnormal_muscle_weight | 0.82641222 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.81821995 |
| 109 | MP0002938_white_spotting | 0.81353240 |
| 110 | MP0003786_premature_aging | 0.80719011 |
| 111 | MP0002006_tumorigenesis | 0.79817083 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.77966208 |
| 113 | MP0004085_abnormal_heartbeat | 0.77414063 |
| 114 | MP0002909_abnormal_adrenal_gland | 0.77077089 |
| 115 | MP0000653_abnormal_sex_gland | 0.76580531 |
| 116 | MP0008004_abnormal_stomach_pH | 0.76378890 |
| 117 | MP0006138_congestive_heart_failure | 0.76043287 |
| 118 | MP0001853_heart_inflammation | 0.75782897 |
| 119 | MP0008007_abnormal_cellular_replicative | 0.75375873 |
| 120 | MP0001145_abnormal_male_reproductive | 0.74397465 |
| 121 | MP0002095_abnormal_skin_pigmentation | 0.74359785 |
| 122 | MP0002067_abnormal_sensory_capabilities | 0.74303702 |
| 123 | MP0005165_increased_susceptibility_to | 0.74086683 |
| 124 | MP0002933_joint_inflammation | 0.73462454 |
| 125 | MP0009250_abnormal_appendicular_skeleto | 0.73350153 |
| 126 | MP0005275_abnormal_skin_tensile | 0.71656790 |
| 127 | MP0001970_abnormal_pain_threshold | 0.71324153 |
| 128 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70918678 |
| 129 | MP0005000_abnormal_immune_tolerance | 0.70205611 |
| 130 | MP0001727_abnormal_embryo_implantation | 0.70040905 |
| 131 | MP0000631_abnormal_neuroendocrine_gland | 0.69861456 |
| 132 | MP0002822_catalepsy | 0.69555936 |
| 133 | MP0005379_endocrine/exocrine_gland_phen | 0.68575541 |
| 134 | MP0003763_abnormal_thymus_physiology | 0.67762876 |
| 135 | MP0001905_abnormal_dopamine_level | 0.65352149 |
| 136 | MP0005084_abnormal_gallbladder_morpholo | 0.64703764 |
| 137 | MP0010368_abnormal_lymphatic_system | 0.61513605 |
| 138 | MP0002420_abnormal_adaptive_immunity | 0.60215553 |
| 139 | MP0003880_abnormal_central_pattern | 0.59748754 |
| 140 | MP0002127_abnormal_cardiovascular_syste | 0.58883523 |
| 141 | MP0002736_abnormal_nociception_after | 0.57667568 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.57637495 |
| 143 | MP0001819_abnormal_immune_cell | 0.57277602 |
| 144 | MP0002398_abnormal_bone_marrow | 0.56355197 |
| 145 | MP0005623_abnormal_meninges_morphology | 0.54825174 |
| 146 | MP0000490_abnormal_crypts_of | 0.53682283 |
| 147 | MP0000358_abnormal_cell_content/ | 0.53153832 |
| 148 | MP0003121_genomic_imprinting | 0.53006216 |
| 149 | MP0000858_altered_metastatic_potential | 0.50870571 |
| 150 | MP0004272_abnormal_basement_membrane | 0.50819883 |
| 151 | MP0003787_abnormal_imprinting | 0.50026454 |
| 152 | MP0002452_abnormal_antigen_presenting | 0.49070358 |
| 153 | MP0002419_abnormal_innate_immunity | 0.49037309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.65036866 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.44083681 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 5.10296976 |
| 4 | Progressive macrocephaly (HP:0004481) | 4.95305429 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.89639932 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.63543167 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 4.61394397 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 4.51156955 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.44904268 |
| 10 | Acute encephalopathy (HP:0006846) | 4.43180785 |
| 11 | Increased CSF lactate (HP:0002490) | 4.43095772 |
| 12 | Hepatocellular necrosis (HP:0001404) | 4.38532025 |
| 13 | Nemaline bodies (HP:0003798) | 4.28512971 |
| 14 | Exercise-induced myalgia (HP:0003738) | 4.08839855 |
| 15 | Hepatic necrosis (HP:0002605) | 4.06502127 |
| 16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.87090743 |
| 17 | Exercise intolerance (HP:0003546) | 3.83489892 |
| 18 | Abnormal number of erythroid precursors (HP:0012131) | 3.63210833 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.61676158 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.61676158 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 3.58737681 |
| 22 | Myoglobinuria (HP:0002913) | 3.44976320 |
| 23 | Distal arthrogryposis (HP:0005684) | 3.37531421 |
| 24 | Type 1 muscle fiber predominance (HP:0003803) | 3.37019173 |
| 25 | Increased hepatocellular lipid droplets (HP:0006565) | 3.36823945 |
| 26 | Increased intramyocellular lipid droplets (HP:0012240) | 3.32533339 |
| 27 | Myotonia (HP:0002486) | 3.27082020 |
| 28 | Abnormality of glycolysis (HP:0004366) | 3.24236400 |
| 29 | Increased serum pyruvate (HP:0003542) | 3.24236400 |
| 30 | Respiratory failure (HP:0002878) | 3.10354398 |
| 31 | Lactic acidosis (HP:0003128) | 3.06818144 |
| 32 | Lipid accumulation in hepatocytes (HP:0006561) | 2.98442911 |
| 33 | Increased muscle lipid content (HP:0009058) | 2.98332762 |
| 34 | Conjunctival hamartoma (HP:0100780) | 2.88002311 |
| 35 | Rhabdomyolysis (HP:0003201) | 2.84767836 |
| 36 | Increased serum lactate (HP:0002151) | 2.82088392 |
| 37 | EMG: myopathic abnormalities (HP:0003458) | 2.78540995 |
| 38 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.75181710 |
| 39 | Abnormality of alanine metabolism (HP:0010916) | 2.75181710 |
| 40 | Hyperalaninemia (HP:0003348) | 2.75181710 |
| 41 | Subaortic stenosis (HP:0001682) | 2.71945579 |
| 42 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.71945579 |
| 43 | Optic disc pallor (HP:0000543) | 2.66484922 |
| 44 | Sudden death (HP:0001699) | 2.63806190 |
| 45 | Esophageal neoplasm (HP:0100751) | 2.63741176 |
| 46 | Neoplasm of head and neck (HP:0012288) | 2.63741176 |
| 47 | Reticulocytopenia (HP:0001896) | 2.56543072 |
| 48 | Ulnar deviation of the wrist (HP:0003049) | 2.56128507 |
| 49 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.55641754 |
| 50 | Muscle stiffness (HP:0003552) | 2.55353061 |
| 51 | Respiratory difficulties (HP:0002880) | 2.53181637 |
| 52 | Palpitations (HP:0001962) | 2.51786292 |
| 53 | Exertional dyspnea (HP:0002875) | 2.49273457 |
| 54 | Ventricular tachycardia (HP:0004756) | 2.48828607 |
| 55 | Calcaneovalgus deformity (HP:0001848) | 2.48821795 |
| 56 | Lipoatrophy (HP:0100578) | 2.45635755 |
| 57 | Renal Fanconi syndrome (HP:0001994) | 2.44810940 |
| 58 | Atrial fibrillation (HP:0005110) | 2.41487204 |
| 59 | Type 2 muscle fiber atrophy (HP:0003554) | 2.36803766 |
| 60 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.36150542 |
| 61 | Supraventricular tachycardia (HP:0004755) | 2.35047060 |
| 62 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.34477252 |
| 63 | Cerebral edema (HP:0002181) | 2.34389150 |
| 64 | Muscle fiber splitting (HP:0003555) | 2.30698166 |
| 65 | Medial flaring of the eyebrow (HP:0010747) | 2.29919549 |
| 66 | Bundle branch block (HP:0011710) | 2.28626801 |
| 67 | Supraventricular arrhythmia (HP:0005115) | 2.27090092 |
| 68 | Lethargy (HP:0001254) | 2.26575321 |
| 69 | Deformed tarsal bones (HP:0008119) | 2.24692537 |
| 70 | Primary atrial arrhythmia (HP:0001692) | 2.24581991 |
| 71 | Hypothermia (HP:0002045) | 2.23119856 |
| 72 | Muscle fiber atrophy (HP:0100295) | 2.21223356 |
| 73 | Large for gestational age (HP:0001520) | 2.19134403 |
| 74 | Myopathic facies (HP:0002058) | 2.18775828 |
| 75 | Rimmed vacuoles (HP:0003805) | 2.14965355 |
| 76 | Round ear (HP:0100830) | 2.12642996 |
| 77 | Neuroendocrine neoplasm (HP:0100634) | 2.12329676 |
| 78 | Increased connective tissue (HP:0009025) | 2.12020422 |
| 79 | Neck muscle weakness (HP:0000467) | 2.11702623 |
| 80 | Glycosuria (HP:0003076) | 2.08990473 |
| 81 | Abnormality of urine glucose concentration (HP:0011016) | 2.08990473 |
| 82 | 3-Methylglutaconic aciduria (HP:0003535) | 2.08475101 |
| 83 | Limb-girdle muscle atrophy (HP:0003797) | 2.07692892 |
| 84 | Dilated cardiomyopathy (HP:0001644) | 2.06929007 |
| 85 | Neoplasm of the adrenal gland (HP:0100631) | 2.06238102 |
| 86 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03437087 |
| 87 | Abnormality of renal resorption (HP:0011038) | 2.02381796 |
| 88 | Methylmalonic acidemia (HP:0002912) | 2.01290406 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.01224795 |
| 90 | Pheochromocytoma (HP:0002666) | 2.00958698 |
| 91 | CNS demyelination (HP:0007305) | 1.99962488 |
| 92 | Absent phalangeal crease (HP:0006109) | 1.97133456 |
| 93 | Left ventricular hypertrophy (HP:0001712) | 1.96543222 |
| 94 | Fetal akinesia sequence (HP:0001989) | 1.96102627 |
| 95 | Pallor (HP:0000980) | 1.94440377 |
| 96 | Weak cry (HP:0001612) | 1.93617972 |
| 97 | Type II lissencephaly (HP:0007260) | 1.93246400 |
| 98 | Leukodystrophy (HP:0002415) | 1.92549140 |
| 99 | Methylmalonic aciduria (HP:0012120) | 1.92541013 |
| 100 | Hyporeflexia of lower limbs (HP:0002600) | 1.92343689 |
| 101 | Nonprogressive disorder (HP:0003680) | 1.91754371 |
| 102 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.91137586 |
| 103 | Molar tooth sign on MRI (HP:0002419) | 1.90593945 |
| 104 | Abnormality of midbrain morphology (HP:0002418) | 1.90593945 |
| 105 | Cerebral hypomyelination (HP:0006808) | 1.90302579 |
| 106 | Poor suck (HP:0002033) | 1.90202732 |
| 107 | Areflexia of lower limbs (HP:0002522) | 1.87494300 |
| 108 | Type I transferrin isoform profile (HP:0003642) | 1.86688575 |
| 109 | X-linked dominant inheritance (HP:0001423) | 1.86232216 |
| 110 | True hermaphroditism (HP:0010459) | 1.86174090 |
| 111 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.85673234 |
| 112 | Aplastic anemia (HP:0001915) | 1.85472827 |
| 113 | Dicarboxylic aciduria (HP:0003215) | 1.84034598 |
| 114 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84034598 |
| 115 | Pancreatic cysts (HP:0001737) | 1.83167430 |
| 116 | Facial diplegia (HP:0001349) | 1.83110998 |
| 117 | Hypoglycemic coma (HP:0001325) | 1.81832105 |
| 118 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.80342863 |
| 119 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.80342863 |
| 120 | Pancreatic fibrosis (HP:0100732) | 1.78071977 |
| 121 | Emotional lability (HP:0000712) | 1.77552093 |
| 122 | Distal lower limb muscle weakness (HP:0009053) | 1.77388822 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.75720441 |
| 124 | Macrocytic anemia (HP:0001972) | 1.72020992 |
| 125 | Thrombocytosis (HP:0001894) | 1.70264285 |
| 126 | Congenital primary aphakia (HP:0007707) | 1.70160541 |
| 127 | Congenital, generalized hypertrichosis (HP:0004540) | 1.69359334 |
| 128 | Bone cyst (HP:0012062) | 1.66535792 |
| 129 | Shoulder girdle muscle weakness (HP:0003547) | 1.66523790 |
| 130 | Gait imbalance (HP:0002141) | 1.65763060 |
| 131 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.65017024 |
| 132 | Ketoacidosis (HP:0001993) | 1.64830603 |
| 133 | Ragged-red muscle fibers (HP:0003200) | 1.64822692 |
| 134 | EMG: neuropathic changes (HP:0003445) | 1.64260750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 3.95877773 |
| 2 | NME2 | 3.57625853 |
| 3 | MAP3K12 | 3.45661955 |
| 4 | MYLK | 2.84810778 |
| 5 | VRK2 | 2.79866724 |
| 6 | TTN | 2.70479776 |
| 7 | NME1 | 2.58096070 |
| 8 | EIF2AK1 | 2.37963548 |
| 9 | MUSK | 2.06873223 |
| 10 | PIM2 | 2.05027158 |
| 11 | ERBB3 | 2.02178979 |
| 12 | CASK | 1.97094530 |
| 13 | PHKG2 | 1.94498198 |
| 14 | PHKG1 | 1.94498198 |
| 15 | ZAK | 1.86709840 |
| 16 | NEK1 | 1.84830318 |
| 17 | VRK1 | 1.84684478 |
| 18 | CDK8 | 1.77133885 |
| 19 | WNK3 | 1.73582270 |
| 20 | BMPR1B | 1.70400105 |
| 21 | STK16 | 1.70027204 |
| 22 | TGFBR1 | 1.67357800 |
| 23 | ILK | 1.66396990 |
| 24 | STK24 | 1.64907691 |
| 25 | MKNK1 | 1.56715895 |
| 26 | NEK9 | 1.53559655 |
| 27 | ACVR1B | 1.51150707 |
| 28 | MAP4K2 | 1.46258474 |
| 29 | PIK3CA | 1.43755545 |
| 30 | CAMKK2 | 1.37460572 |
| 31 | TEC | 1.36622219 |
| 32 | PDK3 | 1.34624507 |
| 33 | PDK4 | 1.34624507 |
| 34 | MAP3K4 | 1.31808461 |
| 35 | TRIM28 | 1.30603005 |
| 36 | DYRK2 | 1.27864612 |
| 37 | FLT3 | 1.27301518 |
| 38 | MST4 | 1.26398925 |
| 39 | PIK3CG | 1.22300691 |
| 40 | GRK7 | 1.19352662 |
| 41 | TNK2 | 1.17749803 |
| 42 | TXK | 1.16545024 |
| 43 | CCNB1 | 1.15928051 |
| 44 | MAPKAPK3 | 1.12262023 |
| 45 | TIE1 | 1.11836334 |
| 46 | MAP2K7 | 1.10345677 |
| 47 | TRPM7 | 1.10207247 |
| 48 | PDK2 | 1.09191530 |
| 49 | CDK19 | 1.06024950 |
| 50 | PAK3 | 1.03018420 |
| 51 | PINK1 | 1.02352845 |
| 52 | FRK | 1.02316619 |
| 53 | IRAK4 | 1.01685743 |
| 54 | CSNK1G3 | 1.00908114 |
| 55 | GRK1 | 1.00833666 |
| 56 | EIF2AK3 | 0.98276066 |
| 57 | CSNK1G2 | 0.97181010 |
| 58 | PLK4 | 0.94848773 |
| 59 | TESK1 | 0.91547800 |
| 60 | TESK2 | 0.89826526 |
| 61 | BMPR2 | 0.86990603 |
| 62 | CSNK1G1 | 0.85602653 |
| 63 | PLK2 | 0.84056678 |
| 64 | TSSK6 | 0.83853279 |
| 65 | KIT | 0.82132607 |
| 66 | BRSK2 | 0.79320417 |
| 67 | KDR | 0.78545331 |
| 68 | YES1 | 0.77092353 |
| 69 | DYRK3 | 0.76483883 |
| 70 | MAP2K3 | 0.76467397 |
| 71 | MARK1 | 0.75342384 |
| 72 | LRRK2 | 0.74511197 |
| 73 | PLK1 | 0.73848074 |
| 74 | TNIK | 0.71783645 |
| 75 | ADRBK2 | 0.71083180 |
| 76 | BUB1 | 0.70989890 |
| 77 | MAPK13 | 0.69721807 |
| 78 | IRAK3 | 0.69511729 |
| 79 | PRKG2 | 0.68972200 |
| 80 | OXSR1 | 0.68531796 |
| 81 | ADRBK1 | 0.67650657 |
| 82 | PRKCG | 0.66989969 |
| 83 | EIF2AK2 | 0.66326207 |
| 84 | INSRR | 0.66232062 |
| 85 | DAPK2 | 0.65717011 |
| 86 | ABL2 | 0.64654739 |
| 87 | CAMK2G | 0.62553303 |
| 88 | PBK | 0.62092339 |
| 89 | IRAK1 | 0.62016955 |
| 90 | MKNK2 | 0.61335000 |
| 91 | TLK1 | 0.61141493 |
| 92 | MINK1 | 0.60891824 |
| 93 | CSNK1A1L | 0.58283657 |
| 94 | STK39 | 0.57575118 |
| 95 | PKN1 | 0.57098004 |
| 96 | LIMK1 | 0.56285343 |
| 97 | MAPKAPK5 | 0.56110760 |
| 98 | DMPK | 0.55903114 |
| 99 | CSNK2A2 | 0.55815447 |
| 100 | WEE1 | 0.54453028 |
| 101 | ARAF | 0.52392330 |
| 102 | SRPK1 | 0.52367769 |
| 103 | BCR | 0.51786659 |
| 104 | SYK | 0.51736688 |
| 105 | DAPK1 | 0.51495644 |
| 106 | LMTK2 | 0.51310699 |
| 107 | CAMK1 | 0.50011278 |
| 108 | BCKDK | 0.49830047 |
| 109 | PASK | 0.49503378 |
| 110 | RPS6KA4 | 0.49501420 |
| 111 | RPS6KA5 | 0.48538738 |
| 112 | MAPK12 | 0.47754726 |
| 113 | PRKG1 | 0.46765034 |
| 114 | RPS6KC1 | 0.45976100 |
| 115 | RPS6KL1 | 0.45976100 |
| 116 | TAF1 | 0.45638219 |
| 117 | BTK | 0.44812840 |
| 118 | GRK5 | 0.43701998 |
| 119 | PKN2 | 0.43678145 |
| 120 | CSNK2A1 | 0.43376608 |
| 121 | AKT2 | 0.42971772 |
| 122 | RPS6KA6 | 0.42876980 |
| 123 | LYN | 0.41092826 |
| 124 | MAP2K6 | 0.39653686 |
| 125 | CDC7 | 0.39256974 |
| 126 | IKBKB | 0.36716914 |
| 127 | MAP3K14 | 0.36141463 |
| 128 | CSNK1A1 | 0.36049232 |
| 129 | PRKCE | 0.35476569 |
| 130 | AURKA | 0.34659112 |
| 131 | PAK4 | 0.34472055 |
| 132 | NUAK1 | 0.34313466 |
| 133 | PAK1 | 0.34306525 |
| 134 | PLK3 | 0.34141297 |
| 135 | PNCK | 0.33929375 |
| 136 | BRAF | 0.33839107 |
| 137 | TBK1 | 0.33390210 |
| 138 | MAP2K4 | 0.33270056 |
| 139 | PRKACG | 0.33255713 |
| 140 | DAPK3 | 0.32942666 |
| 141 | JAK3 | 0.32851335 |
| 142 | AURKB | 0.32820176 |
| 143 | CAMK2D | 0.32453173 |
| 144 | BRSK1 | 0.31985221 |
| 145 | CAMK2A | 0.30835895 |
| 146 | PRKACA | 0.29679729 |
| 147 | PRKCD | 0.27632972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.54246248 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.26926861 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 4.24214399 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.76539338 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 3.06716529 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.98884869 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.89825105 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.74005158 |
| 9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.61861583 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.54997528 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.21460706 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.01483179 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89104386 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.76321644 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.68464536 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.68197191 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.65506159 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.56844307 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.54665079 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.54231570 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.47525697 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.43200158 |
| 23 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.42344234 |
| 24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.42208666 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.40076170 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30280688 |
| 27 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.27990311 |
| 28 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.23430598 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23056462 |
| 30 | Spliceosome_Homo sapiens_hsa03040 | 1.20079056 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.13230497 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.11536532 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11165083 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.10600482 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09232037 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07795469 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.05460909 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.04172086 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.03703276 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02471326 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.02075626 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.00823904 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00597723 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00545972 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00415706 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 0.99011285 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 0.97804474 |
| 48 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.97636865 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 0.93728176 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92812704 |
| 51 | Metabolic pathways_Homo sapiens_hsa01100 | 0.91757370 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 0.90997698 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90514660 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89984554 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85497216 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85436554 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 0.84552403 |
| 58 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.84533806 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84418085 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83574713 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81300497 |
| 62 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.73793440 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73705861 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.73125672 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71586045 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70849865 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69619852 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.68741903 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68534534 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.68197800 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65095112 |
| 72 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64855831 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64271115 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63839552 |
| 75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63422957 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61813184 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61300653 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58199321 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57692508 |
| 80 | RNA transport_Homo sapiens_hsa03013 | 0.56815686 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55810383 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54413323 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.54243140 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.53629127 |
| 85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53172546 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52956120 |
| 87 | Cell cycle_Homo sapiens_hsa04110 | 0.51503501 |
| 88 | Asthma_Homo sapiens_hsa05310 | 0.50702750 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50424584 |
| 90 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48758453 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.48055122 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47942627 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47932259 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47907241 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.46667903 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46539496 |
| 97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46390565 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46028369 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.45820140 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45410550 |
| 101 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.45285646 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44103876 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.43905401 |
| 104 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43218782 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42559203 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42247150 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42213794 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.42213507 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.41718863 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41298740 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41116969 |
| 112 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40639266 |
| 113 | Insulin secretion_Homo sapiens_hsa04911 | 0.39698759 |
| 114 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.39194155 |
| 115 | Basal transcription factors_Homo sapiens_hsa03022 | 0.37708043 |
| 116 | Morphine addiction_Homo sapiens_hsa05032 | 0.37622042 |
| 117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.35380497 |
| 118 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.35131102 |
| 119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34884469 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34744149 |
| 121 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33275926 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33114023 |
| 123 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32661548 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.32312182 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31754408 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31652842 |
| 127 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.31562090 |
| 128 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31278066 |
| 129 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.30811587 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.30571614 |
| 131 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.30522387 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30230789 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30041914 |
| 134 | GABAergic synapse_Homo sapiens_hsa04727 | 0.29475292 |
| 135 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29264217 |
| 136 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.27893217 |
| 137 | Mineral absorption_Homo sapiens_hsa04978 | 0.27472642 |
| 138 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27416666 |
| 139 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27054315 |
| 140 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.27004085 |
| 141 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24495270 |
| 142 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.24255843 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.24193237 |
| 144 | Taste transduction_Homo sapiens_hsa04742 | 0.24128631 |
| 145 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.24124193 |
| 146 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23878088 |
| 147 | Apoptosis_Homo sapiens_hsa04210 | 0.23872063 |
| 148 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22931340 |
| 149 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22398385 |
| 150 | Hepatitis B_Homo sapiens_hsa05161 | 0.22244090 |
| 151 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22082569 |
| 152 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.21945363 |

